- Integer’s adjusted earnings per share (EPS) for the fourth quarter were $1.43, slightly below the estimated $1.46, but higher than last year’s $1.39.
- Sales reached $449.5 million, marking an 8.8% increase from the previous year and surpassing the estimated $446.9 million.
- Adjusted EBITDA increased by 10% year-over-year to $95.1 million, though it fell short of the expected $97.9 million.
- Adjusted operating income was slightly under estimates at $76.0 million compared to the expected $76.4 million.
- For the year 2025, Integer forecasts capital expenditures between $110 million and $120 million.
- The company anticipates 8% to 10% sales growth in 2025, with margins expected to expand.
- Integer expects sales of approximately $7 million from VSi Parylene in 2025 following an acquisition, with a positive impact on margins.
- Adjusted operating income is projected to grow by 11% to 16% in 2025.
- Analyst ratings show strong confidence with 9 buy recommendations, 1 hold, and no sells.
A look at Integer Holdings Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 1 | |
| Growth | 4 | |
| Resilience | 2 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Integer Holdings Corporation, a medical device manufacturing company, shows a promising long-term outlook based on Smartkarma Smart Scores. With strong scores in Growth and Momentum, the company indicates a positive trajectory for expansion and market performance. Integer Holdings’ focus on designing and developing medical devices sets a solid foundation for future growth.
Although facing challenges in the Dividend and Resilience categories, where scores are lower, the overall outlook for Integer Holdings remains optimistic. Investors may find potential in the company’s growth opportunities and market momentum, outweighing concerns in other areas. Serving patients globally, Integer Holdings positions itself as a key player in the medical device industry, promising continued development and innovation in the future.
Summary: Integer Holdings Corporation operates as a medical device manufacturing company, designing and developing medical devices and power solutions for medical and non-medical markets, serving patients worldwide.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
